Testing evidence40 / 50
220 accepted testing records were counted. Held and rejected records stayed out.
Standard grade
Testing, transparency, and catalog integrity data were observed and scored on the current 100-point rubric. Public discussion is not included in the score.
Grade and evidence review: Sep 12, 2026.
How the grade was built · Sep 12, 2026
220 accepted testing records were counted. Held and rejected records stayed out.
8 public identity, policy, catalog, or testing pages were successfully checked.
Listing resolution, exact-basis coverage, freshness, and testing traceability contributed 20 points in the Sep 12, 2026 review.
Public discussion is context only and does not affect this score. Catalog integrity supplies the 30-point third component. Price updates do not change this dated grade.
Open the detailed evidence summary →Catalog and recorded prices
Catalog listings reflect the Sep 12, 2026 review. Price and stock observations can change; compare the exact product and confirm availability with the vendor.
| Compound | Catalog listings | Recorded offers | In stock when observed | Lowest effective price | That price observed | Compare |
|---|---|---|---|---|---|---|
| 5-Amino-1MQ | 4 | 0 | Not recorded | Not available | Not available | View record → |
| AOD-9604 | 1 | 0 | Not recorded | Not available | Not available | View record → |
| ARA-290 | 1 | 0 | Not recorded | Not available | Not available | View record → |
| BPC-157 | 7 | 3 | 3 | $46.755 mg vial | Sep 21, 2026 | Compare this product → |
| Cagrilintide | 1 | 1 | 1 | $157.2510 mg vial | Sep 21, 2026 | Compare this product → |
| Cardiogen | 1 | 1 | 0 | $8020 mg vialOut of stock when observed | Sep 21, 2026 | Compare this product → |
| Cartalax | 1 | 0 | Not recorded | Not available | Not available | View record → |
| CJC-1295 | 2 | 1 | 1 | $65.4510 mg vial | Sep 21, 2026 | Compare this product → |
| CJC-1295/Ipamorelin Blend | 2 | 2 | 2 | $6810 mg vial | Sep 21, 2026 | Compare this product → |
| Dihexa | 3 | 0 | Not recorded | Not available | Not available | View record → |
| DSIP | 2 | 2 | 2 | $515 mg vial | Sep 21, 2026 | Compare this product → |
| Epithalon | 2 | 2 | 2 | $59.5010 mg vial | Sep 21, 2026 | Compare this product → |
| Follistatin | 2 | 1 | 1 | $182.751 mg vial | Sep 21, 2026 | Compare this product → |
| FOXO4-DRI | 1 | 0 | Not recorded | Not available | Not available | View record → |
| GHK-Cu | 2 | 2 | 2 | $55.2550 mg vial | Sep 21, 2026 | Compare this product → |
| GLOW Blend (GHK-Cu/BPC-157/TB-500) | 8 | 2 | 2 | $84.1550 mg vial | Sep 21, 2026 | Compare this product → |
| Gonadorelin | 1 | 1 | 1 | $65.4510 mg vial | Sep 21, 2026 | Compare this product → |
| Hexarelin | 1 | 1 | 1 | $685 mg vial | Sep 21, 2026 | Compare this product → |
| IGF-1 LR3 | 1 | 1 | 1 | $851 mg vial | Sep 21, 2026 | Compare this product → |
| Ipamorelin | 1 | 1 | 1 | $6810 mg vial | Sep 21, 2026 | Compare this product → |
| Kisspeptin-10 | 2 | 2 | 2 | $59.505 mg vial | Sep 21, 2026 | Compare this product → |
| Klotho (Alpha-Klotho) | 1 | 0 | Not recorded | Not available | Not available | View record → |
| KLOW Blend (GHK-Cu/BPC-157/TB-500/KPV) | 1 | 1 | 1 | $148.7580 mg vial | Sep 21, 2026 | Compare this product → |
| KPV | 1 | 1 | 1 | $62.9010 mg vial | Sep 21, 2026 | Compare this product → |
| LL-37 | 3 | 2 | 2 | $755 mg vial | Sep 21, 2026 | Compare this product → |
| Melanotan II | 1 | 1 | 1 | $38.36Automatic quantity fixed amount off · listed $42.5010 mg vial | Sep 21, 2026 | Compare this product → |
| Methylene Blue | 2 | 0 | Not recorded | Not available | Not available | View record → |
| MGF (Mechano Growth Factor) | 1 | 1 | 1 | $127.505 mg vial | Sep 21, 2026 | Compare this product → |
| MOTS-c | 1 | 1 | 1 | $55.2510 mg vial | Sep 21, 2026 | Compare this product → |
| NAD+ | 2 | 1 | 1 | $1701000 mg vial | Sep 21, 2026 | Compare this product → |
| Oxytocin | 1 | 1 | 1 | $55.2510 mg vial | Sep 21, 2026 | Compare this product → |
| P21 | 1 | 1 | 1 | $127.5010 mg vial | Sep 21, 2026 | Compare this product → |
| PE-22-28 | 1 | 1 | 1 | $55.2510 mg vial | Sep 21, 2026 | Compare this product → |
| PEG-MGF | 1 | 1 | 1 | $1195 mg vial | Sep 21, 2026 | Compare this product → |
| PNC-28 | 1 | 0 | Not recorded | Not available | Not available | View record → |
| PT-141 (Bremelanotide) | 2 | 2 | 2 | $515 mg vial | Sep 21, 2026 | Compare this product → |
| Retatrutide | 1 | 0 | Not recorded | Not available | Not available | View record → |
| Selank | 2 | 2 | 2 | $515 mg vial | Sep 21, 2026 | Compare this product → |
| Semaglutide | 4 | 0 | Not recorded | Not available | Not available | View record → |
| Semax | 1 | 1 | 1 | $6830 mg vial | Sep 21, 2026 | Compare this product → |
| Sermorelin | 1 | 1 | 1 | $6810 mg vial | Sep 21, 2026 | Compare this product → |
| SLU-PP-332 | 3 | 0 | Not recorded | Not available | Not available | View record → |
| Survodutide | 1 | 0 | Not recorded | Not available | Not available | View record → |
| TB-500 | 3 | 2 | 2 | $605 mg vial | Sep 21, 2026 | Compare this product → |
| Tesamorelin | 1 | 1 | 1 | $64.6010 mg vial | Sep 21, 2026 | Compare this product → |
| Tesamorelin/Ipamorelin Blend | 2 | 1 | 1 | $80.7515 mg vial | Sep 21, 2026 | Compare this product → |
| Tesofensine | 2 | 0 | Not recorded | Not available | Not available | View record → |
| Thymagen | 1 | 1 | 1 | $11920 mg vial | Sep 21, 2026 | Compare this product → |
| Thymosin Alpha-1 | 2 | 1 | 1 | $97.7510 mg vial | Sep 21, 2026 | Compare this product → |
| Wolverine Blend (BPC-157/TB-500) | 2 | 2 | 2 | $7510 mg vial | Sep 21, 2026 | Compare this product → |